Skip to main content
Top

04-09-2024 | Atrial Fibrillation | REVIEWS

Catheter ablation alone versus catheter ablation with combined percutaneous left atrial appendage closure for atrial fibrillation: a systematic review and meta-analysis

Authors: Joey Junarta, Muhammad U. Siddiqui, Ehab Abaza, Peter Zhang, Aarash Roshandel, Chirag R. Barbhaiya, Lior Jankelson, David S. Park, Douglas Holmes, Larry A. Chinitz, Anthony Aizer

Published in: Journal of Interventional Cardiac Electrophysiology

Login to get access

Abstract

Background

Combined catheter ablation (CA) with percutaneous left atrial appendage closure (LAAC) may produce comprehensive treatment for atrial fibrillation (AF) whereby rhythm control is achieved and stroke risk is reduced without the need for chronic oral anticoagulation. However, the efficacy and safety of this strategy is still controversial.

Methods

This meta-analysis was reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Medline, Scopus, and Cochrane Central Register of Controlled Trials were systematically searched to identify relevant studies. The risk of bias was assessed using the Modified Newcastle-Ottawa scale and Cochrane risk of bias tool. Eligible studies reported outcomes in patients with AF who underwent combined CA and LAAC vs CA alone. Studies performing CA without pulmonary vein isolation were excluded.

Results

Eight studies comprising 1878 patients were included (2 RCT, 6 observational). When comparing combined CA and LAAC vs CA alone, pooled results showed no difference in arrhythmia recurrence (risk ratio (RR) 1.04; 95% confidence interval (CI) 0.82–1.33), stroke or systemic embolism (RR 0.78; 95% CI 0.27–2.22), or major periprocedural complications (RR 1.28; 95% CI 0.28–5.89). Total procedure time was shorter with CA alone (mean difference 48.45 min; 95% CI 23.06–74.62).

Conclusion

Combined CA with LAAC for AF is associated with similar rates of arrhythmia-free survival, stroke, and major periprocedural complications when compared to CA alone. A combined strategy may be as safe and efficacious for patients at moderate to high risk for bleeding events to negate the need for chronic oral anticoagulation.

Graphical Abstract

Literature
1.
go back to reference Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.CrossRefPubMed Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.CrossRefPubMed
2.
go back to reference Wintgens LIS, Klaver MN, Swaans MJ, Alipour A, Balt JC, van Dijk VF, et al. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices. Europace. 2019;21(3):428–33.CrossRefPubMed Wintgens LIS, Klaver MN, Swaans MJ, Alipour A, Balt JC, van Dijk VF, et al. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices. Europace. 2019;21(3):428–33.CrossRefPubMed
3.
go back to reference Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122–35.CrossRefPubMed Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122–35.CrossRefPubMed
4.
go back to reference Black-Maier E, Piccini JP, Granger CB. Left atrial appendage closure: a therapy uniquely suited for specific populations of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30(12):2968–76.CrossRefPubMed Black-Maier E, Piccini JP, Granger CB. Left atrial appendage closure: a therapy uniquely suited for specific populations of patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30(12):2968–76.CrossRefPubMed
5.
go back to reference Price MJ, Reddy VY, Valderrabano M, Halperin JL, Gibson DN, Gordon N, et al. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv. 2015;8(15):1925–32.CrossRefPubMed Price MJ, Reddy VY, Valderrabano M, Halperin JL, Gibson DN, Gordon N, et al. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv. 2015;8(15):1925–32.CrossRefPubMed
6.
go back to reference Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964–75.CrossRefPubMed Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964–75.CrossRefPubMed
7.
go back to reference Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444.CrossRefPubMedPubMedCentral Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017;14(10):e275–444.CrossRefPubMedPubMedCentral
8.
go back to reference Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43(11):2044–53.CrossRefPubMed Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43(11):2044–53.CrossRefPubMed
9.
go back to reference Ikenouchi T, Nitta J, Inaba O, Kono T, Murata K, Takamiya T, et al. Effect of isolation feasibility of non-pulmonary vein foci on efficacy of ablation for atrial fibrillation: comparison of the isolation and focal ablation methods. J Interv Card Electrophysiol. 2022;65(2):441–51.CrossRefPubMed Ikenouchi T, Nitta J, Inaba O, Kono T, Murata K, Takamiya T, et al. Effect of isolation feasibility of non-pulmonary vein foci on efficacy of ablation for atrial fibrillation: comparison of the isolation and focal ablation methods. J Interv Card Electrophysiol. 2022;65(2):441–51.CrossRefPubMed
10.
go back to reference Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109–18.CrossRefPubMed Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109–18.CrossRefPubMed
11.
go back to reference Di Biase L, Burkhardt JD, Mohanty P, Mohanty S, Sanchez JE, Trivedi C, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68(18):1929–40.CrossRefPubMed Di Biase L, Burkhardt JD, Mohanty P, Mohanty S, Sanchez JE, Trivedi C, et al. Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68(18):1929–40.CrossRefPubMed
12.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med. 2009;151(4):264-9. W64 Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med. 2009;151(4):264-9. W64
13.
go back to reference Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.CrossRefPubMed
14.
go back to reference Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;343:d5928-d. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed). 2011;343:d5928-d.
15.
go back to reference Viswanathan M, Patnode CD, Berkman ND, Bass EB, Chang S, Hartling L, et al. Recommendations for assessing the risk of bias in systematic reviews of health-care interventions. J Clin Epidemiol. 2018;97:26–34.CrossRefPubMed Viswanathan M, Patnode CD, Berkman ND, Bass EB, Chang S, Hartling L, et al. Recommendations for assessing the risk of bias in systematic reviews of health-care interventions. J Clin Epidemiol. 2018;97:26–34.CrossRefPubMed
16.
go back to reference Murad MH MV, Ioannidis JPA, Prasad K, Cook DJ, Guyatt G. Advanced topics in systematic reviews: fixed-effects and random-effects models. The JAMA Network: McGraw Hill; 2014. Murad MH MV, Ioannidis JPA, Prasad K, Cook DJ, Guyatt G. Advanced topics in systematic reviews: fixed-effects and random-effects models. The JAMA Network: McGraw Hill; 2014.
17.
go back to reference Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41(3):818–27.CrossRefPubMedPubMedCentral Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol. 2012;41(3):818–27.CrossRefPubMedPubMedCentral
18.
go back to reference Murad MH, Mustafa RA, Schunemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85–7.CrossRefPubMedPubMedCentral Murad MH, Mustafa RA, Schunemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85–7.CrossRefPubMedPubMedCentral
19.
go back to reference Ren Z, Zhang J, Zhu M, Zhao D, Li S, Yang H, et al. Cryoablation combined with left atrial appendage closure: a safe and effective procedure for paroxysmal atrial fibrillation patients. Cardiol Res Pract. 2020;2020:6573296.CrossRefPubMedPubMedCentral Ren Z, Zhang J, Zhu M, Zhao D, Li S, Yang H, et al. Cryoablation combined with left atrial appendage closure: a safe and effective procedure for paroxysmal atrial fibrillation patients. Cardiol Res Pract. 2020;2020:6573296.CrossRefPubMedPubMedCentral
20.
go back to reference Romanov A, Pokushalov E, Artemenko S, Yakubov A, Stenin I, Kretov E, et al. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol. 2015;44(1):9–16.CrossRefPubMed Romanov A, Pokushalov E, Artemenko S, Yakubov A, Stenin I, Kretov E, et al. Does left atrial appendage closure improve the success of pulmonary vein isolation? Results of a randomized clinical trial. J Interv Card Electrophysiol. 2015;44(1):9–16.CrossRefPubMed
21.
go back to reference Panikker S, Jarman JW, Virmani R, Kutys R, Haldar S, Lim E, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9(7). https://doi.org/10.1161/CIRCEP.115.003710 Panikker S, Jarman JW, Virmani R, Kutys R, Haldar S, Lim E, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016;9(7). https://​doi.​org/​10.​1161/​CIRCEP.​115.​003710
22.
go back to reference Yang J, Liu Y, Feng L, Liu M, You L, Liu Y, et al. Effect of Left atrial appendage closure in combination with catheter ablation on left atrial function for persistent atrial fibrillation. Front Cardiovasc Med. 2021;8:666465.CrossRefPubMedPubMedCentral Yang J, Liu Y, Feng L, Liu M, You L, Liu Y, et al. Effect of Left atrial appendage closure in combination with catheter ablation on left atrial function for persistent atrial fibrillation. Front Cardiovasc Med. 2021;8:666465.CrossRefPubMedPubMedCentral
23.
go back to reference Yang J, You L, Liu M, Zhang G, Feng L, Liu Y, et al. Impact of left atrial appendage closure combined with catheter ablation on endocrine and mechanical cardiac function in patients with atrial fibrillation. J Interv Cardiol. 2022;2022:3932912.CrossRefPubMedPubMedCentral Yang J, You L, Liu M, Zhang G, Feng L, Liu Y, et al. Impact of left atrial appendage closure combined with catheter ablation on endocrine and mechanical cardiac function in patients with atrial fibrillation. J Interv Cardiol. 2022;2022:3932912.CrossRefPubMedPubMedCentral
24.
go back to reference Fei Z, Liu M, Yao P, Zhao M, Gong C, Chen M, et al. Effect of combined catheter ablation of atrial fibrillation and left atrial appendage closure on left atrial structure compared with a single procedure. Chin Med J (Engl). 2023;136(24):3010–2.CrossRefPubMed Fei Z, Liu M, Yao P, Zhao M, Gong C, Chen M, et al. Effect of combined catheter ablation of atrial fibrillation and left atrial appendage closure on left atrial structure compared with a single procedure. Chin Med J (Engl). 2023;136(24):3010–2.CrossRefPubMed
25.
go back to reference Mo BF, Sun J, Zhang PP, Li W, Chen M, Yuan JL, et al. Combined therapy of catheter ablation and left atrial appendage closure for patients with atrial fibrillation: a case-control study. J Interv Cardiol. 2020;2020:8615410.CrossRefPubMedPubMedCentral Mo BF, Sun J, Zhang PP, Li W, Chen M, Yuan JL, et al. Combined therapy of catheter ablation and left atrial appendage closure for patients with atrial fibrillation: a case-control study. J Interv Cardiol. 2020;2020:8615410.CrossRefPubMedPubMedCentral
27.
go back to reference Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–156.CrossRefPubMed Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(1):e1–156.CrossRefPubMed
28.
go back to reference Han FT, Bartus K, Lakkireddy D, Rojas F, Bednarek J, Kapelak B, et al. The effects of LAA ligation on LAA electrical activity. Heart Rhythm. 2014;11(5):864–70.CrossRefPubMedPubMedCentral Han FT, Bartus K, Lakkireddy D, Rojas F, Bednarek J, Kapelak B, et al. The effects of LAA ligation on LAA electrical activity. Heart Rhythm. 2014;11(5):864–70.CrossRefPubMedPubMedCentral
29.
go back to reference Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–74.CrossRefPubMedPubMedCentral Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–74.CrossRefPubMedPubMedCentral
30.
go back to reference Kuck KH, Lebedev DS, Mikhaylov EN, Romanov A, Geller L, Kalejs O, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021;23(3):362–9.CrossRefPubMed Kuck KH, Lebedev DS, Mikhaylov EN, Romanov A, Geller L, Kalejs O, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021;23(3):362–9.CrossRefPubMed
31.
go back to reference Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25(2):452–9.CrossRefPubMed Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25(2):452–9.CrossRefPubMed
32.
go back to reference Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42.CrossRefPubMed Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42.CrossRefPubMed
33.
go back to reference Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988–98.CrossRefPubMed Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988–98.CrossRefPubMed
34.
go back to reference Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRefPubMed Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRefPubMed
35.
go back to reference Writing Committee M, Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83(1):109–279.CrossRef Writing Committee M, Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2024;83(1):109–279.CrossRef
36.
go back to reference Douglas YL, Jongbloed MR, Gittenberger-de Groot AC, Evers D, Dion RA, Voigt P, et al. Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation. Am J Cardiol. 2006;97(5):662–70.CrossRefPubMed Douglas YL, Jongbloed MR, Gittenberger-de Groot AC, Evers D, Dion RA, Voigt P, et al. Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation. Am J Cardiol. 2006;97(5):662–70.CrossRefPubMed
37.
go back to reference Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M, et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012;9(12):2003–9.CrossRefPubMed Spragg DD, Khurram I, Zimmerman SL, Yarmohammadi H, Barcelon B, Needleman M, et al. Initial experience with magnetic resonance imaging of atrial scar and co-registration with electroanatomic voltage mapping during atrial fibrillation: success and limitations. Heart Rhythm. 2012;9(12):2003–9.CrossRefPubMed
38.
go back to reference Wang A, Jiang J, Xie Z, Zhong G. Efficacy and safety of catheter ablation combined with left atrial appendage closure in the treatment of atrial fibrillation: a systematic review and meta-analysis. Anatol J Cardiol. 2022;26(3):154–62.CrossRefPubMedPubMedCentral Wang A, Jiang J, Xie Z, Zhong G. Efficacy and safety of catheter ablation combined with left atrial appendage closure in the treatment of atrial fibrillation: a systematic review and meta-analysis. Anatol J Cardiol. 2022;26(3):154–62.CrossRefPubMedPubMedCentral
39.
go back to reference Jiang Y, Li F, Li D, Cheng Y, Jia Y, Fu H, et al. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2020;43(1):123–32.CrossRefPubMed Jiang Y, Li F, Li D, Cheng Y, Jia Y, Fu H, et al. Efficacy and safety of catheter ablation combined with left atrial appendage occlusion for nonvalvular atrial fibrillation: a systematic review and meta-analysis. Pacing Clin Electrophysiol. 2020;43(1):123–32.CrossRefPubMed
40.
go back to reference Li F, Sun JY, Wu LD, Hao JF, Wang RX. The long-term efficacy and safety of combining ablation and left atrial appendage closure: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2021;32(11):3068–81.CrossRefPubMed Li F, Sun JY, Wu LD, Hao JF, Wang RX. The long-term efficacy and safety of combining ablation and left atrial appendage closure: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2021;32(11):3068–81.CrossRefPubMed
Metadata
Title
Catheter ablation alone versus catheter ablation with combined percutaneous left atrial appendage closure for atrial fibrillation: a systematic review and meta-analysis
Authors
Joey Junarta
Muhammad U. Siddiqui
Ehab Abaza
Peter Zhang
Aarash Roshandel
Chirag R. Barbhaiya
Lior Jankelson
David S. Park
Douglas Holmes
Larry A. Chinitz
Anthony Aizer
Publication date
04-09-2024
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-024-01915-7

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now